The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
mTOR is a key modulator of ageing and age-related disease
Open accessAbstract
Many experts in the biology of ageing believe that pharmacological interventions to slow ageing are a matter of 'when' rather than 'if'. A leading target for such interventions is the nutrient response pathway defined by the mechanistic target of rapamycin (mTOR). Inhibition of this pathway extends lifespan in model organisms and confers protection against a growing list of age-related pathologies. Characterized inhibitors of this pathway are already clinically approved, and others are under development. Although adverse side effects currently preclude use in otherwise healthy individuals, drugs that target the mTOR pathway could one day become widely used to slow ageing and reduce age-related pathologies in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the mammalian target of rapamycin (mTOR) pathway, which is induced by amino acids, growth factors, and RT, is often inhibited during CR, and mediates CR-induced health benefits in model organisms [37].”
From Resistance Training Prevents Muscle Loss Induced by Caloric Restriction in Obese Elderly Individuals: A Systematic Review and Meta-Analysis (2018) · cites this paper as [37]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“a well-known inhibitor of mTOR, rapamycin, inhibits the production of SASP factors”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which might explain its beneficial impact on longevity [121,122].”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Genetic down-regulation of mTORC1 activity in yeast, worms and flies extends longevity and attenuates further longevity benefits from DR, suggesting that mTOR inhibition phenocopies DR”
From The Hallmarks of Aging (2013) · cites this paper as Johnson et al., 2013
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Inhibition of mTOR has been shown to extend lifespan and to improve the function of ageing organ systems, including the immune system, in multiple preclinical species.18, 19”
From Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials (2021) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“One of the best validated mechanisms underlying ageing biology is the activity of the protein kinase mTOR.”
From Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials (2021) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“More importantly, these pathways have been evaluated in mammalian models, in which health span and lifespan have been extended by genetic manipulation or drugs (Johnson et al., 2013).”
From Metformin as a tool to target aging (2016) · cites this paper as Johnson et al., 2013
In the citing paper
“Of significance is that metformin, like rapamycin, is known to inhibit mTOR signaling, and the inhibition of the mTOR signaling pathway with rapamycin has been shown to extend lifespan in C. elegans, S. cerevisiae, and Drosophila melanogaster (fruit fly) (221–225).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [224]
In the citing paper
“Of significance is that metformin, like rapamycin, is known to inhibit mTOR signaling, and the inhibition of the mTOR signaling pathway with rapamycin has been shown to extend lifespan in C. elegans, S. cerevisiae, and Drosophila melanogaster (fruit fly) (221–225).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [224]
In the citing paper
“Based on previous studies in the aging field, it is believed that Nrf2 is repressed by mTOR pathway (downstream target); therefore, an inhibition of mTOR by rapamycin would increase the activity of Nrf2 (Johnson et al., 2013).”
From Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism (2017) · cites this paper as Johnson et al., 2013
In the citing paper
“The benefits of nicotinamide riboside can be suppressed by treatment of mice with inhibitors of either SIRT1 or mTOR complex 1 (mTORC1), which is paradoxical as inhibition of mTORC1 signalling normally extends healthspan and lifespan220.”
From Ageing and rejuvenation of tissue stem cells and their niches (2023) · cites this paper as [220]
In the citing paper
“The benefits of nicotinamide riboside can be suppressed by treatment of mice with inhibitors of either SIRT1 or mTOR complex 1 (mTORC1), which is paradoxical as inhibition of mTORC1 signalling normally extends healthspan and lifespan220.”
From Ageing and rejuvenation of tissue stem cells and their niches (2023) · cites this paper as [220]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Autophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766
Aging, natural death, and the compression of morbidity
Fries, J. F. (1980) · New England Journal of Medicine · doi:10.1056/nejm198007173030304 · Cited by 3,356
Extending Healthy Life Span—From Yeast to Humans
Fontana, L., Partridge, L., & Longo, V. D. (2010) · Science · doi:10.1126/science.1172539 · Cited by 3,023
Kenyon, C. J. (2010) · Nature · doi:10.1038/nature08980 · Cited by 2,739
Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
Colman, R. J., Anderson, R. M., Johnson, S. C., Kastman, E. K., Kosmatka, K. J., Beasley, T. M., Allison, D. B., Cruzen, C., Simmons, H. A., Kemnitz, J. W., et al. (2009) · Science · doi:10.1126/science.1173635 · Cited by 2,277
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., et al. (2004) · Nature · doi:10.1038/nature02866 · Cited by 1,677
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,006
MicroRNAs and the metabolic hallmarks of aging
Victoria, B., López, Y. O. N., & Masternak, M. M. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.12.021 · Cited by 64
Long-lived rodents reveal signatures of positive selection in genes associated with lifespan
Sahm, A., Bens, M., Szafranski, K., Holtze, S., Groth, M., Görlach, M., Calkhoven, C. F., Müller, C., Schwab, M. G., Kraus, J. M., et al. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007272 · Cited by 65
Decanoic acid inhibits mTORC1 activity independent of glucose and insulin signaling
Warren, E. C., Dooves, S., Lugarà, E., Damstra‐Oddy, J., Schaf, J., Heine, V. M., Walker, M. C., & Williams, R. S. B. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008980117 · Cited by 66
Transcriptome evidence reveals enhanced autophagy-lysosomal function in centenarians
Xiao, F.-H., Chen, X.-Q., Yu, Q., Ye, Y., Liu, Y.-W., Yan, D., Yang, L.-Q., Chen, G., Lin, R., Yang, L., et al. (2018) · Genome Research · doi:10.1101/gr.220780.117 · Cited by 55
“…SDEGs are from the longevity-associated pathways, such as mTOR, insulin/ IGF-1, and p53 (Supplemental Table S6; Lin et al. 2001; Tavernarakis et al. 2008; Johnson et al. 2013); several of these genes are located in the nodes of the pathways and consistently have the potential to induce autophagy.”
BackgroundShavlakadze, T., Zhu, J., Wang, S., Zhou, W., Morin, B., Egerman, M. A., Fan, L., Wang, Y., Iartchouk, O., Meyer, A., et al. (2018) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glx249 · Cited by 59
Avolio, E., Gianfranceschi, G., Cesselli, D., Caragnano, A., Athanasakis, E., Katare, R., Meloni, M., Palma, A., Barchiesi, A., Vascotto, C., et al. (2014) · Stem Cells · doi:10.1002/stem.1728 · Cited by 62
Genetics of extreme human longevity to guide drug discovery for healthy ageing
Zhang, Z. D., Milman, S., Lin, J.-R., Wierbowski, S. D., Yu, H., Barzilai, N., Gorbunova, V. A., Ladiges, W., Niedernhofer, L. J., Suh, Y., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0247-0 · Cited by 63
Cellular Senescence in Aging Lungs and Diseases
Aghali, A., Ngassie, M. L. K., Pabelick, C. M., & Prakash, Y. S. (2022) · Cells · doi:10.3390/cells11111781 · Cited by 67
“For instance, activation of mTOR upregulates microRNA-34a (miR-34a), and in return inhibits sirtuin-1 (SIRT1) and sirtuin-6 (SIRT6) activities [81,89,90].”
BackgroundSalminen, A. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02444-6 · Cited by 61
“Thus, it is generally believed that mTOR signaling is a major regulator of the aging process and many age-related diseases [131].”
BackgroundGarratt, M., Nakagawa, S., & Simons, M. J. P. (2016) · Aging Cell · doi:10.1111/acel.12489 · Cited by 62
Rapamycin in aging and disease: maximizing efficacy while minimizing side effects
Johnson, S. C., & Kaeberlein, M. R. (2016) · Oncotarget · doi:10.18632/oncotarget.10381 · Cited by 62
Chung, E. J., Sowers, A. L., Thetford, A., McKay-Corkum, G. B., Chung, S. I., Mitchell, J. B., & Citrin, D. E. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.07.026 · Cited by 61
FOXO protects against age‐progressive axonal degeneration
Hwang, I., Oh, H., Santo, E. E., Kim, D., Chen, J. W., Bronson, R. T., Locasale, J. W., Na, Y., Lee, J., Reed, S., et al. (2017) · Aging Cell · doi:10.1111/acel.12701 · Cited by 66
A novel lysosome‐to‐mitochondria signaling pathway disrupted by amyloid‐β oligomers
Norambuena, A., Wallrabe, H., Cao, R., Wang, D. B., Silva, A., Svindrych, Z., Periasamy, A., Hu, S., Tanzi, R. E., Kim, D. Y., et al. (2018) · The EMBO Journal · doi:10.15252/embj.2018100241 · Cited by 61
“Given that mTOR is a key modulator of aging (Johnson et al , 2013) and plays a major regulatory role in the complex cellular machinery that transduces nutrient detection into myriad cellular responses (Efeyan et al , 2015), it is not surprising that dysregulation of NiMA can underlie disease…”
Romine, J., Gao, X., Xu, X., So, K., & Chen, J. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.01.003 · Cited by 62
Targeting the LKB1 Tumor Suppressor
Zhao, R., & Xu, Z. (2014) · Current Drug Targets · doi:10.2174/1389450114666140106095811 · Cited by 64
mTOR controls kidney epithelia in health and disease
Grahammer, F., Wanner, N., & Huber, T. B. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft491 · Cited by 62
The role of the ribosome in the regulation of longevity and lifespan extension
MacInnes, A. W. (2016) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1325 · Cited by 60
Rapamycin Reverses Metabolic Deficits in Lamin A/C-Deficient Mice
Liao, C.-Y., Anderson, S. S., Chicoine, N. H., Mayfield, J., Academia, E. C., Wilson, J. A., Pongkietisak, C., Thompson, M. A., Lagmay, E. P., Miller, D. M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.040 · Cited by 62
Chen, Y., Hamidu, S., Yang, X., Yan, Y., Wang, Q., Li, L., Oduro, P. K., & Li, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.880421 · Cited by 62
“Moreover, mTOR complex activation suppresses lipolysis and autophagy (the degradative signals often likened to cellular homeostasis maintenance) (Johnson et al., 2013; Saxton and Sabatini, 2017).”
BackgroundAntiaging effects of dietary supplements and natural products
Gao, L., Liu, X., Luo, X., Lou, X., Li, P., Li, X., & Liu, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1192714 · Cited by 66
“Enhanced autophagy is not only associated with the aging processes but also implicated in several aging-related pathologies, including cancer, metabolic diseases, and neurodegenerative diseases (Johnson et al., 2013).”
BackgroundRegulation of the H+-ATP synthase by IF1: a role in mitohormesis
Esparza‐Moltó, P. B., Nuevo‐Tapioles, C., & Cuezva, J. M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2462-8 · Cited by 64
Aging, Metabolism, and Cancer Development: from Peto’s Paradox to the Warburg Effect
Tidwell, T., Søreide, K., & Hagland, H. R. (2017) · Aging and Disease · doi:10.14336/ad.2017.0713 · Cited by 64
“Calorie restriction and associated dietary restriction seem to exert their effects specifically through mTOR, AMPK, and glucose handling (IGF/insulin) pathways [138, 139] with outcomes such as lifespan extension, reduced inflammation and cancer.”
BackgroundInfluentialThe effect of caloric restriction and fasting on cancer
Alidadi, M., Banach, M., Guest, P. C., Bo, S., Jamialahmadi, T., & Sahebkar, A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.09.010 · Cited by 63
Metformin: A Dual-Role Player in Cancer Treatment and Prevention
Galal, M. A., Al-Rimawi, M., Hajeer, A., Dahman, H., Alouch, S. S., & Aljada, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074083 · Cited by 73
“Metformin enhances cellular resilience and metabolic function and counteracts age-related degradation by modulating AMPK/mTOR [161].”
Cao, L., Tang, Y., Quan, Z., Zhang, Z., Oliver, S. G., & Zhang, N. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006458 · Cited by 64
Huy, H., Song, H. Y., Kim, M. J., Kim, W. S., Kim, D. O., Byun, J., Lee, J., Park, Y., Kim, T., Yoon, S. R., et al. (2018) · Aging Cell · doi:10.1111/acel.12836 · Cited by 60
“Intracellular ROS induce AKT activation, which in turn induces premature senescence by increasing ROS levels via inhibition of the transcriptional activity of the FOXO family and by activating mTOR pathways (Dolado & Nebreda, 2008; Johnson et al., 2013; Sheu et al., 2004; Zhao et al., 2017).”
BackgroundNew Insights into the Role of Exercise in Inhibiting mTOR Signaling in Triple‐Negative Breast Cancer
Agostini, D., Natalucci, V., Baldelli, G., Santi, M. D., Zeppa, S. D., Vallorani, L., Annibalini, G., Lucertini, F., Federici, A., Izzo, R., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/5896786 · Cited by 62
“CR increases the level of the circulating adiponectin, which can exert anticancer effects through mechanisms that include an increase in insulin sensitivity, a decrease in insulin/IGF-1 and mTOR signaling via AMPK activation as well as a reduction in the proinflammatory cytokine expression via inhibition of the nuclea…”
BackgroundRepurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke
Sharma, S., Nozohouri, S., Vaidya, B., & Abbruscato, T. J. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119343 · Cited by 62
The flavonoid corylin exhibits lifespan extension properties in mouse
Wang, T., Tseng, W.-C., Leu, Y., Chen, C., Chi, Y.-C., Chi, Y.-C., Cheng, S.-F., Lai, C.-Y., Kuo, C.-H., Yang, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28908-2 · Cited by 61
Caloric restriction - A promising anti-cancer approach: From molecular mechanisms to clinical trials
Kopeina, G. S., Senichkin, V. V., & Zhivotovsky, B. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.11.002 · Cited by 59
Catic, A. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.12.003 · Cited by 58
p53 Isoforms in Cellular Senescence- and Ageing-Associated Biological and Physiological Functions
Fujita, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236023 · Cited by 59
The therapeutic landscape of hepatocellular carcinoma
Gallage, S., Beccaria, M. G., Szydlowska, M., Rahbari, M., Mohr, R. U., Tacke, F., & Heikenwälder, M. F. (2021) · Med · doi:10.1016/j.medj.2021.03.002 · Cited by 61
Melnik, B. C. (2015) · Current Diabetes Reviews · doi:10.2174/1573399811666150114100653 · Cited by 59
Natural Compounds and Aging: Between Autophagy and Inflammasome
Chuang, S.-Y., Lin, C.-H., & Fang, J. (2014) · BioMed Research International · doi:10.1155/2014/297293 · Cited by 59
Álvarez-García, Ó., Olmer, M., Akagi, R., Akasaki, Y., Fisch, K. M., Shen, T., Su, A. I., & Lotz, M. (2016) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2016.04.015 · Cited by 60
Janssens, G. E., & Veenhoff, L. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167394 · Cited by 61
The role of mitochondria in mTOR‐regulated longevity
Wei, Y., Zhang, Y., Cai, Y., & Xu, M. (2015) · Biological Reviews · doi:10.1111/brv.12103 · Cited by 56
The Naked Mole-Rat as a Model for Healthy Aging
Oka, K., Yamakawa, M., Kawamura, Y., Kutsukake, N., & Miura, K. (2022) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-050322-074744 · Cited by 59
Liao, C., & Kennedy, B. K. (2014) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-397920-9.00003-2 · Cited by 59
Adult-onset obesity is triggered by impaired mitochondrial gene expression
Perks, K. L., Ferreira, N., Richman, T. R., Ermer, J. A., Kuznetsova, I., Shearwood, A.-M. J., Lee, R. G., Viola, H. M., Johnstone, V., Matthews, V. B., et al. (2017) · Science Advances · doi:10.1126/sciadv.1700677 · Cited by 56
Manolagas, S. C. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3400 · Cited by 60
“The list includes inhibitors of themTOR pathway, metformin and acarbose.((81,82)) Cellular reprogramming to pluripotency by transient expression of the Yamanaka factors can also ameliorate age-associated symptoms, prolong lifespan in progeroid mice, and increase resistance to metabolic diseases and muscle injury homeo…”
BackgroundAntiaging Strategies and Remedies: A Landscape of Research Progress and Promise
Tenchov, R., Sasso, J. M., Wang, X., & Zhou, Q. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00532 · Cited by 62
The biochemistry and cell biology of aging: metabolic regulation through mitochondrial signaling
Long, Y. C., Tan, T. M. C., Inoue, T., & Tang, B. L. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00665.2013 · Cited by 57
Melnik, B. C., John, S. M., & Schmitz, G. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-014-0377-9 · Cited by 59
Lung tissue gene-expression signature for the ageing lung in COPD
de Vries, M., Faiz, A., Woldhuis, R. R., Postma, D. S., de Jong, T. V., Sin, D. D., Bossé, Y., Nickle, D. C., Guryev, V., Timens, W., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2017-210074 · Cited by 56
Kremer, L. P. M., Korb, J., & Bornberg‐Bauer, E. (2018) · Journal of Experimental Zoology Part B Molecular and Developmental Evolution · doi:10.1002/jez.b.22809 · Cited by 53
Temporal changes in the gene expression heterogeneity during brain development and aging
Işıldak, U., Somel, M., Thornton, J. M., & Dönertaş, H. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-60998-0 · Cited by 53
Emerging Role of C/EBPβ and Epigenetic DNA Methylation in Ageing
Niehrs, C., & Calkhoven, C. F. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.11.005 · Cited by 54
Meta‐lens light‐sheet fluorescence microscopy for in vivo imaging
Luo, Y., Tseng, M. L., Vyas, S., Hsieh, T.-Y., Wu, J.-C., Chen, S.-Y., Peng, H. ‐., Su, V., Huang, T., Kuo, H. Y., et al. (2022) · Nanophotonics · doi:10.1515/nanoph-2021-0748 · Cited by 54
Bigagli, E., Luceri, C., Scartabelli, T., Dolara, P., Casamenti, F., Pellegrini-Giampietro, D. E., & Giovannelli, L. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glu231 · Cited by 56
Pomegranate Juice Enhances Healthy Lifespan in Drosophila melanogaster: An Exploratory Study
Balasubramani, S. P., Jayaram, M., Chatterjee, A., Patnaik, E., Kukkupuni, S. K., Nongthomba, U., & Venkatasubramanian, P. (2014) · Frontiers in Public Health · doi:10.3389/fpubh.2014.00245 · Cited by 54
Preparing for an Aging World: Engaging Biogerontologists, Geriatricians, and the Society
Nikolich‐Žugich, J., Goldman, D. P., Cohen, P. R., Cortese, D. A., Fontana, L., Kennedy, B. K., Mohler, M. J., Olshansky, S. J., Perls, T. T., Perry, D. P., et al. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv164 · Cited by 58
Green, C. L., Mitchell, S. E., Derous, D., Wang, Y., Chen, L., Han, J. J., Promislow, D., Lusseau, D., Douglas, A., & Speakman, J. R. (2017) · Aging Cell · doi:10.1111/acel.12570 · Cited by 53
Understanding the mTOR signaling pathway via mathematical modeling
Sulaimanov, N., Klose, M., Busch, H. S., & Boerries, M. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1379 · Cited by 54
OncomiR-17-5p: alarm signal in cancer?
Bobbili, M. R., Mader, R. M., Grillari, J., & Dellago, H. (2017) · Oncotarget · doi:10.18632/oncotarget.19331 · Cited by 54
“During the process of aging, autophagy maintains cellular function by removing protein aggregates and allowing degradation of aged cellular components [45].”
BackgroundEffects of hunger on neuronal histone modifications slow aging in Drosophila
Weaver, K. J., Holt, R. A., Henry, E., Lyu, Y., & Pletcher, S. D. (2023) · Science · doi:10.1126/science.ade1662 · Cited by 61
Kawai, M., Kinoshita, S., Ozono, K., & Michigami, T. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015040446 · Cited by 55
Unraveling the message: insights into comparative genomics of the naked mole-rat
Lewis, K. N., Soifer, I., Melamud, E., Roy, M. A., McIsaac, R. S., Hibbs, M., & Buffenstein, R. (2016) · Mammalian Genome · doi:10.1007/s00335-016-9648-5 · Cited by 53
Does eating less make you live longer and better? An update on calorie restriction
Picca, A., Pesce, V., & Lezza, A. M. S. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s126458 · Cited by 57
“133 The mTOR inhibition has been largely identified as a longevity assurance mechanism, 133 and the availability of rapamycin and other mTOR inhibitors makes this pathway a valuable target for interventions to extend healthspan.”
Contreras, N. A., Fontana, L., Tosti, V., & Nikolich‐Žugich, J. (2018) · GeroScience · doi:10.1007/s11357-018-0022-2 · Cited by 53
The clock is ticking: the impact of ageing on T cell metabolism
Quinn, K. M., Palchaudhuri, R., Palmer, C. S., & Gruta, N. L. L. (2019) · Clinical & Translational Immunology · doi:10.1002/cti2.1091 · Cited by 52
“The impact of metabolism on ageing is mediated at least in part by the PI3KAkt-mTOR signalling pathway, as inhibition of mTOR can significantly extend lifespan in multiple different species, including yeast, nematodes and mice.(83) mTOR is therefore a highly conserved regulator of both metabolism and longevity.”
BackgroundJustice, J. N., Gubbi, S., Kulkarni, A. S., Bartley, J. M., Kuchel, G. A., & Barzilai, N. (2020) · GeroScience · doi:10.1007/s11357-020-00261-6 · Cited by 53
The Review of Anti-aging Mechanism of Polyphenols on Caenorhabditis elegans
Liu, L., Guo, P., Wang, P., Zheng, S., Qu, Z., & Liu, N. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.635768 · Cited by 52
“Among the various anti-aging methods and preventive strategies, the use of micronutrients or biologically active substances is considered a practical and efficient method that targets a variety of intracellular/extracellular pathways (Sahin et al., 2011; Johnson et al., 2013; Li et al., 2017).”
BackgroundLin, J.-R., Sin‐Chan, P., Napolioni, V., Torres, G. G., Mitra, J., Zhang, Q., Jabalameli, M. R., Wang, Z., Nguyen, N., Gao, T., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00108-5 · Cited by 52
IFNγ-Stat1 axis drives aging-associated loss of intestinal tissue homeostasis and regeneration
Omrani, O., Křepelová, A., Rasa, S. M. M., Širvinskas, D., Lu, J. N., Annunziata, F., Garside, G. B., Bajwa, S., Reinhardt, S., Adam, L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41683-y · Cited by 54
“For example, mTOR and Sirtuin signaling pathways, two well-known pathways in the aging fi eld 54,55 , were differentially enriched and regulated between old female and male intestinal crypts.”
Staying young at heart: autophagy and adaptation to cardiac aging
Leon, L. J., & Gustafsson, Å. B. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.006 · Cited by 53
Nutrient sensing pathways as therapeutic targets for healthy ageing
Aiello, A., Accardi, G., Candore, G., Gambino, C. M., Mirisola, M. G., Taormina, G., Virruso, C., & Caruso, C. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1294684 · Cited by 52
Horvath, S., Lu, A. T.-H., Cohen, H., & Raj, K. (2019) · Aging · doi:10.18632/aging.101976 · Cited by 51
“It acts to promote many processes including, but not limited to protein synthesis, autophagy, lipid synthesis and glycolysis [29, 43, 44].”
BackgroundZhong, S.-J., Wang, L., Gu, R.-Z., Zhang, W.-H., Lan, R., & Qin, X. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.43979 · Cited by 52
“However, compelling evidence has supported the longevity effect through the inhibition of mTOR activity [37].”
BackgroundKhorraminejad‐Shirazi, M., Sani, M., Talaei‐Khozani, T., Dorvash, M., Mirzaei, M., Faghihi, M. A., Monabati, A., & Attar, A. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-1565-6 · Cited by 51
Cerebral insulin, insulin signaling pathway, and brain angiogenesis
Zeng, Y., Zhang, L., & Hu, Z. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2386-8 · Cited by 51
Ageing stem and progenitor cells: implications for rejuvenation of the central nervous system
van Wijngaarden, P., & Franklin, R. J. M. (2013) · Development · doi:10.1242/dev.092262 · Cited by 53
mTOR Inhibition: From Aging to Autism and Beyond
Kaeberlein, M. R. (2013) · Scientifica · doi:10.1155/2013/849186 · Cited by 52
Lei, L., Ou, L., & Yu, X. (2016) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2015.06.023 · Cited by 51
Molina‐Serrano, D., Schiza, V., Demosthenous, C., Stavrou, E., Oppelt, J., Kyriakou, D., Liu, W., Zisser, G., Bergler, H., Dang, W., et al. (2016) · EMBO Reports · doi:10.15252/embr.201642540 · Cited by 48
Filippone, S. M., Samidurai, A., Roh, S. K., Cain, C. K., He, J., Salloum, F. N., Kukreja, R. C., & Das, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4619720 · Cited by 52
Langdon, S., Hughes, A. M., Taylor, M. A., Kuczynski, E. A., Mele, D. A., Delpuech, O., Jarvis, L., Staniszewska, A. D., Cosulich, S. C., Carnevalli, L. S., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1458810 · Cited by 52
“infection or vaccination,(36,48) and that mTOR plays a generalized role to limit biological lifespan.(49) In addition, given that mTOR inhibition is known to promote autophagy,(50) our results may extend findings by Xu et al.”
Saedi, A. A., Goodman, C. A., Myers, D. E., Hayes, A., & Duque, G. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz149 · Cited by 52
Role of Molecular Hydrogen in Ageing and Ageing‐Related Diseases
Fu, Z., Zhang, J., & Zhang, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2249749 · Cited by 53
“Therefore, mTOR is a key modulator of ageing and age-related disease [92].”
Big mice die young but large animals live longer
Blagosklonny, M. V. (2013) · Aging · doi:10.18632/aging.100551 · Cited by 52
Pollizzi, K. N., Waickman, A. T., Patel, C. H., Sun, I., & Powell, J. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121710 · Cited by 51
Oral health in geroscience: animal models and the aging oral cavity
An, J. Y., Darveau, R. P., & Kaeberlein, M. R. (2017) · GeroScience · doi:10.1007/s11357-017-0004-9 · Cited by 51
Knockout of receptor for advanced glycation end‐products attenuates age‐related renal lesions
Teissier, T., Quersin, V., Gnemmi, V., Daroux, M., Howsam, M., Delguste, F., Lemoine, C., Fradin, C., Schmidt, A., Cauffiez, C., et al. (2019) · Aging Cell · doi:10.1111/acel.12850 · Cited by 56
Pharmacological convergence reveals a lipid pathway that regulates C. elegans lifespan
Chen, A. L., Lum, K. M., Lara-González, P., Ogasawara, D., Cognetta, A. B., To, A., Parsons, W. H., Simon, G. M., Desai, A. B., Petrascheck, M., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0243-4 · Cited by 51
Citrulline regulates macrophage metabolism and inflammation to counter aging in mice
Xie, Z., Lin, M., Xing, B., Wang, H., Zhang, H., Cai, Z., Mei, X., & Zhu, Z. (2025) · Science Advances · doi:10.1126/sciadv.ads4957 · Cited by 51
“Extensive research has established the mTOR pathway as a negative regulator of lifespan and aging ( 49 , 50 ).”
Jiao, Z. J., Wang, Y., Rong, Y., Jeong, D. K., & Zhong, W. (2015) · Endocrinology · doi:10.1210/en.2014-1982 · Cited by 49
Derous, D., Mitchell, S. E., Wang, L., Green, C. L., Wang, Y., Chen, L., Han, J. J., Promislow, D., Lusseau, D., Douglas, A., et al. (2017) · Aging · doi:10.18632/aging.101269 · Cited by 49
“These are reduced insulin/insulin like growth factor (IGF-1) signaling [15,35,36], reduced mechanistic target of rapamycin (mTOR) signaling [37], reduced nuclear factor-kappa beta (NF-κB) signaling [38] and increased sirtuin signaling [39].”
Shen, T., Li, H., Song, Y., Li, L., Lin, J., Wei, G., & Ni, T. (2019) · Aging · doi:10.18632/aging.101836 · Cited by 48
Xie, R., Wang, P., Cheng, M., Sapolsky, R. M., Ji, X., & Zhao, H. (2014) · Stroke · doi:10.1161/strokeaha.114.005406 · Cited by 48
Immunosuppressants in cancer prevention and therapy
Blagosklonny, M. V. (2013) · OncoImmunology · doi:10.4161/onci.26961 · Cited by 48
Verburgh, K. (2014) · Aging Cell · doi:10.1111/acel.12284 · Cited by 51
Rapamycin and Ageing: When, for How Long, and How Much?
Kaeberlein, M. R. (2014) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2014.06.009 · Cited by 49
Practical alternatives to chronic caloric restriction for optimizing vascular function with ageing
Martens, C. R., & Seals, D. R. (2016) · The Journal of Physiology · doi:10.1113/jp272348 · Cited by 49
NutrimiRAging: Micromanaging Nutrient Sensing Pathways through Nutrition to Promote Healthy Aging
Micó, V., Berninches, L., Tapia, J., & Daimiel, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050915 · Cited by 50
Das, R., Melo, J. A., Thondamal, M., Morton, E. A., Cornwell, A., Crick, B., Kim, J. H., Swartz, E. W., Lamitina, T., Douglas, P. M., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1007038 · Cited by 46
Li, Z., Wang, Y., Wang, H.-J., Wu, J.-H., & Tan, Y. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-09952-1 · Cited by 48
Aging, cytomegalovirus (CMV) and influenza vaccine responses
Frasca, D., & Blomberg, B. B. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1105413 · Cited by 46
Attinà, A., Leggeri, C., Paroni, R., Pivari, F., Dei Cas, M., Mingione, A., Dri, M., Marchetti, M., & Di Renzo, L. (2021) · Nutrients · doi:10.3390/nu13051570 · Cited by 47
“In the absence of malnutrition, reduction in nutrient intake extends lifespan in many different species thanks to the mTORC1 inhibition [27].”
Background
Metadata
- Authors
- Johnson, S. C., Rabinovitch, P. S., & Kaeberlein, M.
- Affiliations
- University of Washington (US)
- Guangdong Medical College (CN)
- Corresponding author
- Kaeberlein, Matt
- Venue
- Nature
- Published
- 2013-01-16
- Volume
- 493
- Issue
- 7432
- Pages
- 338-345
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3687363
- OpenAlex
- W2010583480
- Cited by
- 1,676
- References
- 100
- Citations by year
- 2026: 87 · 2025: 82 · 2024: 117 · 2023: 121 · 2022: 113 · 2021: 164 · 2020: 136 · 2019: 140 · 2018: 125 · 2017: 133 · 2016: 136 · 2015: 119 · 2014: 131 · 2013: 72
- FWCI
- 9.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG031108, T32AG000057, P01AG001751, R01AG039390, R01AG038550, P30AG013280)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- mTOR, aging, age-related diseases, lifespan extension, rapamycin, mTOR inhibitors, pharmacological interventions
- MeSH terms
- Aging, Animals, Humans, Insulin, Insulin-Like Growth Factor I, Longevity, Signal Transduction, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
